BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6326535)

  • 21. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 22. Peptide mapping of cyclic nucleotide phosphodiesterases.
    Takemoto DJ; Hansen J; Takemoto LJ; Houslay MD; Marchmont RJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():55-64. PubMed ID: 6326536
    [No Abstract]   [Full Text] [Related]  

  • 23. Calmodulin-dependent cyclic nucleotide phosphodiesterase from bovine eye: high calmodulin affinity isozyme immunologically related to the brain 60-kDa isozyme.
    Sharma RK; Tan Y; Raju RV
    Arch Biochem Biophys; 1997 Mar; 339(1):40-6. PubMed ID: 9056231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Itoh H; Hidaka H
    J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and properties of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Sharma RK; Wang TH; Wirch E; Wang JH
    J Biol Chem; 1980 Jun; 255(12):5916-23. PubMed ID: 6247353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation and activation of calmodulin-sensitive cyclic nucleotide phosphodiesterase by a brain Ca2+, calmodulin-dependent protein kinase.
    Fukunaga K; Yamamoto H; Tanaka E; Iwasa T; Miyamoto E
    Life Sci; 1984 Jul; 35(5):493-9. PubMed ID: 6087066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calmodulin-dependent cyclic AMP phosphodiesterase in liver plasma membranes: stimulated by insulin.
    Smoake JA; Moy GM; Fang B; Solomon SS
    Arch Biochem Biophys; 1995 Nov; 323(2):223-32. PubMed ID: 7487081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Neurospora crassa cyclic AMP phosphodiesterase activated by calmodulin.
    Téllez-Iñón MT; Ulloa RM; Glikin GC; Torres HN
    Biochem J; 1985 Dec; 232(2):425-30. PubMed ID: 3004404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY; Loh HH
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review.
    Sharma RK; Das SB; Lakshmikuttyamma A; Selvakumar P; Shrivastav A
    Int J Mol Med; 2006 Jul; 18(1):95-105. PubMed ID: 16786160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of proteolysis on the calmodulin activation of cyclic nucleotide phosphodiesterase.
    Tucker MM; Robinson JB; Stellwagen E
    J Biol Chem; 1981 Sep; 256(17):9051-8. PubMed ID: 6267061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subunit structure and catalytic properties of bovine brain Ca2+-dependent cyclic nucleotide phosphodiesterase.
    Klee CB; Crouch TH; Krinks MH
    Biochemistry; 1979 Feb; 18(4):722-9. PubMed ID: 217423
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of streptozotocin-induced diabetes on phosphodiesterase activity in rat luteal cells.
    Stein P; Téllez-Iñón MT; Tesone M
    Mol Reprod Dev; 1996 Sep; 45(1):43-7. PubMed ID: 8873068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase.
    Lam HY
    Biochem Biophys Res Commun; 1984 Jan; 118(1):27-32. PubMed ID: 6320825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of calmodulin by various metal cations as a function of ionic radius.
    Chao SH; Suzuki Y; Zysk JR; Cheung WY
    Mol Pharmacol; 1984 Jul; 26(1):75-82. PubMed ID: 6087119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The activation of brain adenylate cyclase and brain cyclic-nucleotide phosphodiesterase by seven calmodulin derivatives.
    Thiry P; Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
    Eur J Biochem; 1980 Jan; 103(2):409-14. PubMed ID: 6244945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies.
    Sharma RK; Adachi AM; Adachi K; Wang JH
    J Biol Chem; 1984 Jul; 259(14):9248-54. PubMed ID: 6086630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme.
    Kakkar R; Raju RV; Rajput AH; Sharma RK
    Brain Res; 1997 Feb; 749(2):290-4. PubMed ID: 9138729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of nicergoline on reaction kinetics of various forms of cyclic AMP phosphodiesterase.
    Pericin D; Leskovac V
    Arzneimittelforschung; 1981; 31(12):2082-5. PubMed ID: 6277342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.